Evidence for endogenous urotensin-II as an inhibitor of insulin secretion. Study in the perfused rat pancreas.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Peptides

• Publication date

  2008-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.PEPTIDES.2007.08.025PMID 17931748
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus.

  2009cited by this paper
• Urotensin-II and UII-receptor expression and function in the rat adrenal cortex.

  2006cited by this paper
• The Urotensin-II Receptor Antagonist Palosuran Improves Pancreatic and Renal Function in Diabetic Rats

  2006cited by this paper
• Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro.

  2006cited by this paper
• Urotensin-II is present in pancreatic extracts and inhibits insulin release in the perfused rat pancreas.

  2004cited by this paper
• Unraveling the active conformation of urotensin II.

  2004cited by this paper
• Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy.

  2004cited by this paper
• Translational medicine in fish-derived peptides: from fish endocrinology to human physiology and diseases.

  2004cited by this paper
• Pharmacology of the Urotensin-II Receptor Antagonist Palosuran (ACT-058362; 1-[2-(4-Benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea Sulfate Salt): First Demonstration of a Pathophysiological Role of the Urotensin System

  2004cited by this paper
• Increased plasma urotensin II levels in patients with diabetes mellitus.

  2003cited by this paper
• Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure.

  2003cited by this paper
• Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain.

  2003cited by this paper
• Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?

  2003cited by this paper
• Structure–Activity Relationships of Human Urotensin II and Related Analogues on Rat Aortic Ring Contraction

  2003cited by this paper
• Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta

  2003cited by this paper
• Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects

  2003cited by this paper
• Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II.

  2002cited by this paper
• Molecular and pharmacological characterization of genes encoding urotensin‐II peptides and their cognate G‐protein‐coupled receptors from the mouse and monkey

  2002cited by this paper
• Plasma urotensin II in heart failure.

  2002cited by this paper
• [The role of urotensin II gene in the genetic susceptibility to type 2 diabetes in Chinese population].

  2002cited by this paper
• Plasma Urotensin in Human Systolic Heart Failure

  2002cited by this paper
• Role of androgens in the regulation of urotensin II precursor mRNA expression in the rat brainstem and spinal cord.

  2002cited by this paper
• Congestive heart failure and expression of myocardial urotensin II.

  2002cited by this paper
• Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists.

  2002cited by this paper
• Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model.

  2002cited by this paper
• Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat.

  2001cited by this paper
• Role of urotensin II in patients on dialysis.

  2001cited by this paper
• Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension.

  2001cited by this paper
• Inhibition of Insulin Release by Urotensin II - A Study on the Perfused Rat Pancreas

  2001cited by this paper
• Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease.

  2000cited by this paper
• Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research.

  2000cited by this paper
• Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin.

  1999cited by this paper
• Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction

  1999cited by this paper
• Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

  1999cited by this paper
• Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).

  1999cited by this paper
• Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.

  1999cited by this paper
• Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors

  1999cited by this paper
• Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord.

  1998cited by this paper
• Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives.

  1997cited by this paper
• Immunoassay of endogenous plasma insulin in man.

  1996cited by this paper
• Aspartic Acid Residue 124 in the Third Transmembrane Domain of the Somatostatin Receptor Subtype 3 Is Essential for Somatostatin-14 Binding

  1995cited by this paper
• Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors.

  1995cited by this paper
• A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia.

  1995cited by this paper
• Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SSTR2.

  1995cited by this paper
• Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda.

  1992cited by this paper
• Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat.

  1986cited by this paper
• Primary structures of multiple forms of urotensin II in the urophysis of the carp, Cyprinus carpio.

  1984cited by this paper
• Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat.

  1982cited by this paper
• Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes.

  1980cited by this paper
• Coated charcoal immunoassay of insulin.

  1965cited by this paper
• Immunoassay of Endogenous Plasma Insulin in Man

  1960cited by this paper
• Non-Parametric Statistics for the Behavioral Sciences.

  1957cited by this paper

• Urotensin II system in chronic kidney disease

  2024cites this paper
• Targeting Islet GPCRs to Improve Insulin Secretion

  2021cites this paper
• Plasma Urotensin II Concentration In Gestational Diabetes

  2017cites this paper
• International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II–Related Peptide, and Their Receptor: From Structure to Function

  2015influential citation
• Molecular evolution of GPCRs: Somatostatin/urotensin II receptors.

  2014cites this paper
• Urotensin-II System in Genetic Control of Blood Pressure and Renal Function

  2013cites this paper
• An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans.

  2013cites this paper
• Analysis of genetic variation within urotensin-II system in regulation of blood pressure and renal function

  2013cites this paper
• Association Between Thr21Met and Ser89Asn Polymorphisms of the Urotensin-II (UTS2) Gene, Diabetes Mellitus, and Diabetic Retinopathy

  2012cites this paper
• Association Analysis of Urotensin II Gene (UTS2) and Flanking Regions with Biochemical Parameters Related to Insulin Resistance

  2011cites this paper
• Role of urotensin II in health and disease.

  2010cites this paper
• Urotensin II, from fish to human

  2010cites this paper
• Raised Plasma Urotensin II in Type 2 Diabetes Patients Is Associated With the Metabolic Syndrome Phenotype

  2010cites this paper
• Urotensin II Receptor Knockout Mice on an ApoE Knockout Background Fed a High-Fat Diet Exhibit an Enhanced Hyperlipidemic and Atherosclerotic Phenotype

  2009cites this paper
• Characterization of the insulinostatic effect of urotensin II: a study in the perfused rat pancreas.

  2009cites this paper
• Structure-activity relationships of urotensin II and URP.

  2008cites this paper
• Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues

  2008influential citation
• Urotensin II is an autocrine/paracrine growth factor for aortic adventitia of rat.

  2008cites this paper
• Urotensin II and urotensin II-related peptide activate somatostatin receptor subtypes 2 and 5.

  2008cites this paper
• Urotensin Ii Receptor Knockout Mice on an Apoe Knockout Background Fed a High-fat Diet Exhibit an Enhanced Hyperlipidemic and Atherosclerotic Phenotype Lesion Area Fraction

  year unknowncites this paper